Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
74,190,609
-
Total 13F shares
-
22,704,562
-
Share change
-
+215,937
-
Total reported value
-
$24,525,621
-
Price per share
-
$1.08
-
Number of holders
-
55
-
Value change
-
+$283,842
-
Number of buys
-
23
-
Number of sells
-
34
Institutional Holders of ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) as of Q3 2014
As of 30 Sep 2014,
ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,704,562 shares.
The largest 10 holders included
ICAHN CARL C, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BRANDES INVESTMENT PARTNERS, LP, SCHRODER INVESTMENT MANAGEMENT GROUP, BlackRock Advisors LLC, Cove Street Capital, LLC, and UBS AG.
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.